Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002480921 | SCV002790849 | uncertain significance | Joubert syndrome 7; Meckel syndrome, type 5; COACH syndrome 3 | 2022-02-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002542956 | SCV003714902 | uncertain significance | Inborn genetic diseases | 2022-06-21 | criteria provided, single submitter | clinical testing | The c.1143G>C (p.K381N) alteration is located in exon 10 (coding exon 9) of the RPGRIP1L gene. This alteration results from a G to C substitution at nucleotide position 1143, causing the lysine (K) at amino acid position 381 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001280354 | SCV001467530 | uncertain significance | Familial aplasia of the vermis | 2020-04-24 | no assertion criteria provided | clinical testing |